Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Advanced Course on Deep Dive in CDK4-6 Inhibitors Data in Breast Cancer 2023: Dubai

20 - 20 May 2023

Dubai, United Arab Emirates

ESMO-Advanced-Courses-Breast-Cancer-1000x1000

Resources from ESMO Advanced Courses are exclusively for participants and ESMO Members according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The use of these presentations is for personal educational purposes only.

Learning Objectives
  • Understanding the function and biology of CDK4-6 in malignant breast cancer cells
  • Information and in-depth discussion on the state of the art and emerging therapeutic strategies integrating CDK4-6 inhibition in breast cancer, both in the metastatic setting
  • Presenting novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of CDK4-6 inhibition
  • Providing an outlook of potential integration of CDK 4-6 inhibitors in the adjuvant setting
  • Discussing clinical cancer cases to integrate use of CDK 4-6 inhibitors in clinical practice

This event has been supported by an unrestricted educational grant from Novartis.

Hide
Filter by:

There are 9 resources available

Welcome and introduction

Presenter: G. Curigliano, IT, B. Pistilli, FR

Session: Opening and welcome

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.